Status:
UNKNOWN
Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD
Lead Sponsor:
Nantes University Hospital
Conditions:
ADHD
Eligibility:
All Genders
9-16 years
Phase:
NA
Brief Summary
Attention Deficit Disorder with or without Hyperactivity (ADHD) is a frequent pathology in children that has important consequences on schooling both in terms of academic level (due to the attentional...
Eligibility Criteria
Inclusion
- Patients aged 9-16 years old with ADHD assessed by Conners 3 scales
- Parents and children giving informed consent
- Patients in follow-up list of participant centers
- Patients with unchanging care for the last 3 months (medication and therapy)
Exclusion
- Patients with severe psychiatric disease such as schizophrenia, bipolar disorder, or autism spectrum disorders and suicidal behavior (all assessed by Child Behavior Checklist Scale)
- Patients with no smartphone or not easy access to smartphone (ie patients of social facilities, internship…)
- Patients with mild to severe mental retardation or that may obviously not be able to use the app
- Patients included in special program other the Care as Usual (defined in the ADHD French network) in follow-up list.
- Patients with Methylphenidate treatment or change of titration for less than 3 months.
Key Trial Info
Start Date :
January 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2024
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT04857788
Start Date
January 11 2022
End Date
March 15 2024
Last Update
November 15 2023
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Berquin
Amiens, France
2
Bioulac
Bordeaux, France
3
Fourneret
Lyon, France
4
Purpuer
Montpellier, France